Free Trial

NeuBase Therapeutics (NBSE) Insider Trading & Ownership

→ The Crypto 9-5 Escape Plan (From Crypto 101 Media) (Ad)
Free NBSE Stock Alerts
$0.38
0.00 (0.00%)
(As of 05/14/2024 ET)
Compare
Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability

NeuBase Therapeutics (NASDAQ:NBSE) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
7.90%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$59,854.48
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$325,510.56
Get NBSE Insider Trade Alerts

Want to know when executives and insiders are buying or selling NeuBase Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

NBSE Insider Buying and Selling by Quarter

Ad Chaikin Analytics
Did Intel Just Dethrone Nvidia?
Intel (INTC) just announced a brand-new AI venture - the Aurora supercomputer. This computer was specifically designed for artificial intelligence and is now the fastest AI-centered computer on the planet.
You can get all the details here.

NeuBase Therapeutics Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/14/2023Corp SymetryxMajor ShareholderSell129,108$1.44$185,915.52  
9/11/2023Corp SymetryxMajor ShareholderSell3,376$1.44$4,861.44  
9/7/2023Corp SymetryxMajor ShareholderSell74,852$1.80$134,733.60  
9/1/2023Corp SymetryxMajor ShareholderBuy61,076$0.98$59,854.48  
(Data available from 1/1/2013 forward)

NBSE Insider Trading Activity - Frequently Asked Questions

Who is on NeuBase Therapeutics's Insider Roster?

The list of insiders at NeuBase Therapeutics includes Corp Symetryx, Eric I Richman, Todd P Branning, and William Roland Mann. Learn more on insiders at NBSE.

What percentage of NeuBase Therapeutics stock is owned by insiders?

7.90% of NeuBase Therapeutics stock is owned by insiders. Learn more on NBSE's insider holdings.

Which NeuBase Therapeutics insiders have been buying company stock?

The following insider purchased NBSE shares in the last 24 months: Corp Symetryx ($59,854.48).

How much insider buying is happening at NeuBase Therapeutics?

Insiders have purchased a total of 61,076 NBSE shares in the last 24 months for a total of $59,854.48 bought.

Which NeuBase Therapeutics insiders have been selling company stock?

The following insider sold NBSE shares in the last 24 months: Corp Symetryx ($325,510.56).

How much insider selling is happening at NeuBase Therapeutics?

Insiders have sold a total of 207,336 NeuBase Therapeutics shares in the last 24 months for a total of $325,510.56 sold.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:NBSE) was last updated on 5/14/2024 by MarketBeat.com Staff

From Our Partners
Did Intel Just Dethrone Nvidia?
Chaikin Analytics
Revolutionizing the Green Energy Space and Building Shareholder Value Along the Way
Small Cap Sniper
Claim Your Complimentary Bitcoin Reward
Crypto Swap Profits
Tech GIANT’s Plans to Revolutionize Crypto…
Crypto 101 Media
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press
Charles Payne Demystifies Options
Unstoppable Prosperity
Elon to Transform U.S. Economy?
Porter & Company
Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years
Banyan Hill Publishing